Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
None listed
Sponsors
Dr Rakesh
Eligibility
Inclusion criteria
Inclusion criteria: Metabolically stable diabetic Subjects with symptomatic Diabetic Peripheral Neuropathy. Subjects fulfilling the diagnostic criteria. Subjects whose HbA1c is between 6.5 to 9%. Subjects of all gender between the age group of 40 - 65 years
Exclusion criteria
Exclusion criteria: Subjects whose HbA1c is more than 9%. Subjects with other metabolic and endocrinal disorders. Subjects with other causes of Polyneuropathy. Subjects suffering from infectious diseases and non healing ulcer/ulcers. Subjects with cardiac aliments and Nephropathy. Subjects with Diabetic Neuropathy in stage N3 of Dyck’s staging
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vibration Perception Threshold (VPT) on BIOTHESIOMETER Before and After the TreatmentTimepoint: 1st Assessment – Before Treatment (0th day) 2nd Assessment – During Treatment (31st day) 3rd Assessment – During Treatment (61st day) 4th Assessment – After Treatment (91st day) | — |
Secondary
| Measure | Time frame |
|---|---|
| Diabetic Neuropathy Symptom (DNS) questionnaire Score Before and After the Treatment Diabetic Neuropathy Examination Score (DNE) Before and After the Treatment Visual Analog Scale (VAS) Before and After the Treatment WHO Quality of Life (WHO QoL) BREF Before and After the Treatment Timepoint: 1st Assessment – Before Treatment (0th day) 2nd Assessment – During Treatment (31st day) 3rd Assessment – During Treatment (61st day) 4th Assessment – After Treatment (91st day) | — |
Countries
India
Contacts
Public ContactDr Rakesh
Government Ayurveda Medical College, Mysuru
Outcome results
None listed